Immediate Impact
6 by Nobel laureates 7 from Science/Nature 59 standout
Citing Papers
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
2025 Standout
Hallmarks of neurodegenerative diseases
2023 Standout
Works of Katherine Riester being referenced
Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
2015
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Katherine Riester | 611 | 350 | 268 | 417 | 41 | 1.4k | |
| Caroline Besson | 940 | 343 | 782 | 297 | 83 | 2.0k | |
| N Cappello | 308 | 359 | 240 | 618 | 54 | 1.9k | |
| Maya Ram | 308 | 507 | 127 | 600 | 59 | 2.0k | |
| Michael J. Kornstein | 408 | 233 | 524 | 424 | 58 | 2.0k | |
| Benedicte A. Lie | 228 | 559 | 131 | 261 | 35 | 1.4k | |
| C. Larroche | 334 | 736 | 290 | 246 | 63 | 2.2k | |
| Yolanda Benavente | 390 | 227 | 472 | 474 | 57 | 1.5k | |
| Rubén D. Mantilla | 255 | 418 | 73 | 205 | 44 | 1.8k | |
| Daniëlle Cohen | 172 | 474 | 197 | 255 | 53 | 1.8k | |
| E Díaz-Jouanen | 236 | 515 | 136 | 245 | 57 | 1.5k |
All Works
Loading papers...